Copyright
©The Author(s) 2020.
World J Gastroenterol. Feb 21, 2020; 26(7): 696-705
Published online Feb 21, 2020. doi: 10.3748/wjg.v26.i7.696
Published online Feb 21, 2020. doi: 10.3748/wjg.v26.i7.696
Table 1 Biomarkers in inflammatory bowel disease
| Marker | Setting | Diagnostic accuracy | Ref. |
| C-Reactive Protein (CRP) | Serum | Higher in CD vs UC | Henriksen et al[24], 2008 |
| 25% IBD patients have levels above normal | Vermeire et al[22], 2004 | ||
| Anti-Saccharomyces cerevisiae Antibodies (ASCA) | Serum | 39%-79% CD positive | Peyrin-Biroulet et al[25], 2015; |
| 5%-15% UC positive | Reumaux et al[26], 2004 | ||
| 14%-18% HC positive | Bennike et al[27], 2014 | ||
| Anti-neutrophil cytoplasmic antibodies (ANCA) | Serum | Different pattern in CD and UC | Peeters et al[31], 2001; |
| Peyrin-Biroulet et al[30], 2007; | |||
| Reumaux et al[29], 2003 | |||
| 32% HC positive | Bernstein et al[32], 2011 | ||
| Calprotectin | Colorectal mucus | Higher in IBD vs HC | Loktionov et al[79], 2016 |
| Higher in UC vs CD | |||
| Calgranulin C (S100A12) | Higher in UC vs CD | ||
| Eosinophil-derived neurotoxin (EDN) | Higher in IBD vs HC | ||
| Higher in UC vs CD | |||
| Fecal calprotectin (FC) | Stool | It correlates with disease activity in adults | Gisbert et al[35], 2009 |
| Lactoferrin | Stool | It distinguishes IBD from IBS | Bennike et al[27], 2014 |
Table 2 Proteomics in inflammatory bowel disease pathogenesis
| Protein | Setting | Diagnostic accuracy | Ref. |
| Lactotransferrin | UC vs HC biopsies | It correlates to the colon inflammation grade score | Bennike et al[53], 2015 |
| Neutrophil extracellular traps (NETs) | Sign of chronic inflammation | ||
| Granzyme B and Perforin | CD Th1 and Th17 clones from intestinal mucosa | Higher in Th1 vs Th17 | Riaz et al[58], 2016 |
| RORC and FOXP3 | |||
| Glycerol-3-phosphatedehydrogenase | UC biopsies inflamed vs non-inflamed | Higher in inflamed vs non-inflamed tissue | Poulsen et al[60], 2012 |
| Alphaenolase | Lower in inflamed vs non- inflamed tissue | ||
| Keratins 10, 14, 19 | UC intestinal epithelial cells | Higher in QUC vs HC | Moriggi et al[61], 2017 |
| Keratin 8 | Lower in QUC vs HC | ||
| Tricarboxylic acid cycle enzymes | |||
| Oxidative phosphorylation enzymes | |||
| Vinculin and α-tubulin | |||
| Keratin 8, 18 | CD intestinal epithelial cells | Lower in QCD vs HC | |
| Heat shock cognate-70 (HSC70) | |||
| Vinculin and α-tubulin | Higher in QCD vs HC | ||
| Fibrinopeptide A (FPA) | CD serum | Higher in CD vs HC | Nanni et al[62], 2009 |
| Complement 3 protein (C3) | |||
| Apolipoprotein A-IV | |||
| Apolipoprotein E | Lower in CD vs HC | ||
| L-lactate dehydrogenase | IBD and HC intestinal epithelial cells | Higher in IBD vs HC; Higher in CD vs UC | Shkoda et al[63], 2007 |
| Carbonyl reductase | |||
| Keratin 19 | |||
| Rho-GDI dissociation inhibitor α | |||
| Annexin 2 | UC intestinal epithelial cells | Higher in UC vs HC | |
| Programmed cell death protein 8 (PDCD8) |
Table 3 Proteomics in inflammatory bowel disease diagnosis and response to therapy
| Proteins | Setting | Diagnostic accuracy | Ref. |
| Platelet aggregation factor 4 (PF4) | Responder vs non-responder’s CD serum | Higher in non-responders | Mewuis et al[69], 2008 |
| Proteins that regulate CD4+ T-cell activation | Serum before IFX treatment vs serum after IFX induction period | Higher before treatment | Gazouli et al[73], 2013 |
| Proteins that regulate monocytes/macrophages activation | |||
| Tenascin C | Responder vs non-responder’s UC serum | Higher in non-responders | Magnusson et al[74], 2015 |
- Citation: Pisani LF, Moriggi M, Gelfi C, Vecchi M, Pastorelli L. Proteomic insights on the metabolism in inflammatory bowel disease. World J Gastroenterol 2020; 26(7): 696-705
- URL: https://www.wjgnet.com/1007-9327/full/v26/i7/696.htm
- DOI: https://dx.doi.org/10.3748/wjg.v26.i7.696
